v3.25.2
Note 11 - Commitments and Contingencies
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]

11. Commitments and Contingencies

 

Operating Leases

 

The Company determines if an arrangement is a lease at inception of the contract. The Company has operating leases for buildings, primarily for office space, manufacturing, and distribution, as well as automobiles and printing equipment. As of June 30, 2025, the Company had the following building and facility leases capitalized on the balance sheet:

 

Location (leases)

 

Purpose

 

Approx. Sq. Ft.

 

Expiration

               

Americas

             

Burlington, MA (4)

 

Corporate headquarters and manufacturing

    96,476  

December 2034

North Brunswick, NJ

 

Artegraft biologic business

    16,732  

October 2029

Burlington, MA

 

US distribution

    12,878  

December 2030

Fox River Grove, IL

 

RestoreFlow allografts business

    9,754  

December 2026

Fox River Grove, IL

 

RestoreFlow allografts business

    4,878  

November 2025

Vaughn, Canada

 

Canada sales office and distribution

    3,192  

February 2026

               

Europe, Middle East and Africa

             

Sulzbach, Germany

 

European headquarters and distribution

    21,410  

June 2031

Milan, Italy

 

Italy sales office and distribution

    5,705  

September 2027

Hereford, England

 

United Kingdom sales office and distribution

    3,575  

October 2029

Maisons-Alfort, France

 

France sales office

    3,492  

February 2030

Zurich, Switzerland

 

Switzerland sales office and distribution

    2,935  

February 2030

Madrid, Spain

 

Spain sales office and distribution

    2,260  

June 2029

               

Asia Pacific

             

Tokyo, Japan

 

Japan sales office and distribution

    4,236  

July 2027

Shanghai, China

 

China sales office and distribution

    3,432  

October 2027

Docklands, Australia

 

Australia sales office and distribution

    2,863  

April 2030

Bangkok, Thailand

 

Thailand sales office and distribution

    2,810  

August 2026

Seoul, Korea

 

Korea sales office and distribution

    2,300  

April 2027

Singapore

 

Asia Pacific headquarters and distribution

    1,270  

June 2026

Ballarat, Australia

 

Supply facility

 

Up to 350 acres

 

December 2030

 

Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future lease minimum payments over the lease term at commencement date. Many of the lease agreements contain renewal or termination clauses that are factored into the determination of the lease term if it is reasonably certain that these options would be exercised. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

None of the Company’s noncancelable lease payments include non-lease components such as maintenance contracts. The Company generally reimburses the landlord for direct operating costs associated with the leased space. The Company has no subleases, and there are no residual value guarantees associated with, or restrictive covenants imposed by, any of its leases. The Company held no assets under capital leases as of June 30, 2025. The Company elected the package of practical expedients that allow it to omit leases with initial terms of 12 months or less from its balance sheet, which the Company expenses on a straight-line basis over the life of the lease.

 

The interest rate implicit in lease agreements is typically not readily determinable, and as such the Company used the incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The incremental borrowing rate is defined as the interest the Company would pay to borrow on a collateralized basis.

 

Additional information with respect to the Company’s leases is as follows:

 

   

Three months ended June 30,

   

Six months ended June 30,

 
   

2025

   

2024

   

2025

   

2024

 
   

(in thousands)

   

(in thousands)

 

Lease cost

                               

Operating lease cost

  $ 447     $ 709     $ 1,041     $ 1,149  

Short-term lease cost

    20       17       46       46  

Total lease cost

  $ 467     $ 726     $ 1,087     $ 1,195  
                                 

Weighted average remaining lease term - operating leases (in years)

                    6.9       7.8  
                                 

Weighted average discount rate - operating leases

                    6.62 %     6.60 %

 

As of June 30, 2025, the minimum noncancelable operating lease rental commitments with initial or remaining terms of more than one year are as follows:

 

Remainder of 2025

  $ 2,035  

Year ending December 31,

       

2026

    3,612  

2027

    3,030  

2028

    2,759  

2029

    2,695  

2030

    2,186  

Thereafter

    6,420  

Adjustment to net present value as of June 30, 2025

    (5,053 )
         

Minimum noncancelable lease liability

  $ 17,684  

 

In June 2025, the Company executed a new building lease agreement in Billerica, Massachusetts for U.S. distribution. The 34,400 square foot building lease will commence on January 1, 2026, with a primary term through December 31, 2032. The Company has the option to renew the primary term of the lease for one additional 24-month period.